CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy - Alves, Wilson Eduardo Furlan Matos; Bonatelli, Murilo; Dufloth, Rozany Mucha; Kerr, Ligia Maria; Carrara, Guilherme Freire Angotti; Costa, Ricardo Filipe Alves da; Scapulatempo Neto, Cristovam; Tiezzi, Daniel Guimarães; Vieira, René Aloísio da Costa; Pinheiro, Celine Marques (BMC Cancer, 2019)